Typical medullary breast carcinoma (MBC) has recently been recognized to be part of the basal-like carcinoma spectrum, a feature in agreement with the high rate of TP53 mutations previously reported in MBCs. This evidence concerns the gene TP53 and maternal uniparental disomy of chromosome 20.